← Company directoryNASDAQ · SEC EDGAR

Zymeworks Inc.

ZYME

A primary-source company identity page built for fast discovery, filing verification and consistent financial research.

SHARE PRICE · INDICATIVE——

A recent price could not be verified. Check the exchange before trading.

LATEST REVENUE…Verify in official filing

MATCHED NET INCOME…No normalized match

PRIMARY SOURCESECIssuer identity and filings

ANALYSIS ROUTE

Four checks before any decision

Business model

Understand how the company earns and where demand originates.

Revenue and margin

Compare equivalent periods; separate growth from profitability.

Debt and cash flow

Test balance-sheet resilience and cash conversion.

Valuation and risk

Use sector peers, scenarios and explicit risk limits.

Company calendar

Nov 9, 2026November 9 US date · after market close; exact time not announced

Zymeworks Q3 2026 financial results

Third-quarter results will be released after US markets close November 9. The company does not plan an earnings conference call or webcast. Financial performance of licensed healthcare assets and biotherapeutic development is in focus.

Zymeworks ↗

DISCOVERY NETWORK

More NASDAQ records

Alphabetically adjacent directory records for faster navigation; this is not a peer or valuation classification.

PSQLPasqal Holding SANASDAQ · SEC→DEVSDevvStream Corp.NASDAQ · SEC→NFEGPNew Fortress Energy Inc. Series A Mandatorily Convertible Preferred StockNASDAQ · SEC→KRSAKorsana Biosciences, Inc.NASDAQ · SEC→

DATA STATUS

Checking SEC financial statements

A dash means standardized data is unavailable. Always check the filing period, currency and accounting scope.

Open official filings ↗